None listed
Conditions
Interventions
Medical Device : Treatments were performed by a trained investigator who had no knowledge of the subjects’ group assignment. During each session, a direct current was transferred using a saline-soaked
Sponsors
Korea University Anam Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) duration of RLS = 1 year, 2) having symptoms = 3 times per week, and 3) International RLS Study Group Rating Scale (IRLS) = 20, indicating severe symptomatology
Exclusion criteria
Exclusion criteria: 1) significant comorbidities likely to be associated with secondary RLS, such as anemia, pregnancy, chronic kidney disease, or peripheral neuropathy, 2) presence of cognitive disorders that prevented participants from describing their symptoms, 3) presence of disorders with symptoms similar to RLS, such as attention deficit hyperactivity disorder, essential tremor, Parkinson’s disease, neuroleptic-induced akathisia, congestive heart failure, vascular claudication, neurogenic claudication, myelopathy, and arthritis , 4) those who were taking medications that can affect the central nervous system, and 5) those who had metallic objects in their bodies, such as a pacemaker or internal metallic objects in the brain.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IRLS (the International Restless Legs Syndrome Study Group Rating Scale);CGI(Clinical Global Impression) global improvement, | — |
Secondary
| Measure | Time frame |
|---|---|
| PGI(Patient Global Impression) change;PGI(Patient Global Impression) change;the Pittsburgh Sleep Quality Index;the Medical Outcome Study (MOS) sleep subscales;the Korean version of the Beck Depression Inventory, version II (BDI-II);visual analog scale (VAS) scores ;Subjective Post-Sleep Diary (SPSD);type, frequency, and severity of adverse effects | — |
Countries
Korea, Republic of
Contacts
Public ContactMI-Ae Lee
Korea University Anam Hospital
Outcome results
None listed